European regulators to look at developing new criteria for assessing diagnostic imaging agents
This article was originally published in Clinica
Executive Summary
The European Medicines Evaluation Agency (EMEA) will look at how it reviews diagnostic imaging agents in an attempt to decide how best to assess the efficacy of these products.